Toshiba America Medical Systems (TAMS), a subsidary of Toshiba, has received the US Food and Drug Administration (FDA) approval for its VirtualExplorer Version 3.1, a software upgrade package for Toshiba MR VirtualExplorer workstations.
VirtualExplorer Version 3.1 includes features such as 3D image visualization, DICOM Viewer, 2D filming, Double Oblique and Virtual Endoscope.
The Cardiac Edition of the software upgrade also includes features specific to cardiac imaging, such as MR Flow Analysis, MR Cardiac Analysis, MR Coronary Analysis and Delayed Enhancement.
Additionally, the Neuro Edition of the software includes Brain Perfusion for neuro evaluation.
Toshiba MR Business Unit director Stuart Clarkson said with advanced features like MR Flow Analysis, clinicians have the ability to streamline cardiac diagnosis for patient care.
TAMS markets, sells, distributes and services diagnostic imaging systems, and coordinates clinical diagnostic imaging research for all modalities in the US.